Sanofi Fires Back Against Mylan In Its Bid To Exit EpiPen MDL
Sanofi-Aventis US LLC told a Kansas federal court Friday that Mylan Inc. missed the mark when pointing to overlaps between Sanofi's case accusing the EpiPen maker of employing anti-competitive tactics and...To view the full article, register now.
Already a subscriber? Click here to view full article